IRIS Accounts Production v24.3.0.553 11901002 director 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119010022023-03-31119010022024-03-31119010022023-04-012024-03-31119010022022-03-31119010022022-04-012023-03-31119010022023-03-3111901002ns15:EnglandWales2023-04-012024-03-3111901002ns14:PoundSterling2023-04-012024-03-3111901002ns10:Director12023-04-012024-03-3111901002ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3111901002ns10:SmallEntities2023-04-012024-03-3111901002ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3111901002ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3111901002ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111901002ns10:FullAccounts2023-04-012024-03-3111901002ns10:OrdinaryShareClass12023-04-012024-03-3111901002ns10:OrdinaryShareClass22023-04-012024-03-3111901002ns10:OrdinaryShareClass32023-04-012024-03-3111901002ns10:OrdinaryShareClass42023-04-012024-03-3111901002ns5:CurrentFinancialInstruments2024-03-3111901002ns5:CurrentFinancialInstruments2023-03-3111901002ns5:ShareCapital2024-03-3111901002ns5:ShareCapital2023-03-3111901002ns5:RetainedEarningsAccumulatedLosses2024-03-3111901002ns5:RetainedEarningsAccumulatedLosses2023-03-3111901002ns10:RegisteredOffice2023-04-012024-03-3111901002ns5:ComputerEquipment2023-03-3111901002ns5:ComputerEquipment2023-04-012024-03-3111901002ns5:ComputerEquipment2024-03-3111901002ns5:ComputerEquipment2023-03-3111901002ns10:OrdinaryShareClass12024-03-3111901002ns10:OrdinaryShareClass22024-03-3111901002ns10:OrdinaryShareClass32024-03-3111901002ns10:OrdinaryShareClass42024-03-31119010021ns10:Director12023-03-31119010021ns10:Director12022-03-31119010021ns10:Director12023-04-012024-03-31119010021ns10:Director12022-04-012023-03-31119010021ns10:Director12024-03-31119010021ns10:Director12023-03-31
REGISTERED NUMBER: 11901002 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st March 2024

for

Moor Anaesthesia Services Limited

Moor Anaesthesia Services Limited (Registered number: 11901002)






Contents of the Financial Statements
for the Year Ended 31st March 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Moor Anaesthesia Services Limited (Registered number: 11901002)

Balance Sheet
31st March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 374 670

CURRENT ASSETS
Debtors 5 1,995 1,508
Cash at bank 33,392 16,160
35,387 17,668
CREDITORS
Amounts falling due within one year 6 18,492 6,290
NET CURRENT ASSETS 16,895 11,378
TOTAL ASSETS LESS CURRENT
LIABILITIES

17,269

12,048

PROVISIONS FOR LIABILITIES 71 127
NET ASSETS 17,198 11,921

CAPITAL AND RESERVES
Called up share capital 7 103 103
Retained earnings 17,095 11,818
SHAREHOLDERS' FUNDS 17,198 11,921

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 17th November 2024 and were signed by:





Dr S Dolling - Director


Moor Anaesthesia Services Limited (Registered number: 11901002)

Notes to the Financial Statements
for the Year Ended 31st March 2024

1. COMPANY INFORMATION

Moor Anaesthesia Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11901002

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or
valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual
values over their useful lives on the following basis:

Computer Equipment - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the
sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Moor Anaesthesia Services Limited (Registered number: 11901002)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1st April 2023
and 31st March 2024 1,668
DEPRECIATION
At 1st April 2023 998
Charge for year 296
At 31st March 2024 1,294
NET BOOK VALUE
At 31st March 2024 374
At 31st March 2023 670

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 1,995 1,508

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Tax 7,168 1,659
Directors' current accounts 10,696 4,036
Accrued expenses 628 595
18,492 6,290

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
100 Ordinary A £1 100 100
1 Ordinary B £1 1 1
1 Ordinary C £1 1 1
1 Ordinary D £1 1 1
103 103

Moor Anaesthesia Services Limited (Registered number: 11901002)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

7. CALLED UP SHARE CAPITAL - continued

The ordinary A shares confer on the holders the right to vote upon any resolution proposed
at any general meeting of the company.

The ordinary B shares do not confer on the holders the right to vote upon any resolution
proposed at any general meeting of the company.

The ordinary C shares do not confer on the holders the right to vote upon any resolution
proposed at any general meeting of the company.

The ordinary D shares do not confer on the holders the right to vote upon any resolution
proposed at any general meeting of the company.

The ordinary A, B, C and D shares rank Dr Stuart Dolling in respect of dividend and capital distribution
rights.

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st March 2024 and 31st March 2023:

31.3.24 31.3.23
£    £   
Dr S Dolling
Balance outstanding at start of year (4,036 ) (8,206 )
Amounts advanced 17,500 16,460
Amounts repaid (24,160 ) (12,290 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (10,696 ) (4,036 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr S Dolling by virtue of holding 100% of the voting share capital.